---
title: Divi's Laboratories vs Flamma
slug_a: divislabs
slug_b: flammagroup
site: cdmo
review_signal_gate: closed
canonical_path: /compare/divislabs/flammagroup
---

# Divi's Laboratories vs Flamma

Side-by-side profile data from each company listing on this directory.

## Divi's Laboratories

- Profile: [/companies/divislabs](/companies/divislabs)

Divi's Laboratories — World's largest API manufacturer and trusted CDMO partner for 25+ years, offering generic APIs, custom synthesis, peptides, and nutraceutical ingredients to 100+ countries with complete backward integration and green chemistry principles.

Services: 9. Modalities: 2. Indications: 0. Locations: 7. Certifications: 0. The strongest documented coverage currently appears in services (9).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Peptide Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Analytical method development
- Formulation development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- HPAPI
- Flow Chemistry

## Flamma

- Profile: [/companies/flammagroup](/companies/flammagroup)

Flamma — Privately held small molecule CDMO with FDA-inspected cGMP facilities in Italy, USA, and China, offering custom manufacturing, development, and specialized technologies including HPAPI, continuous flow, and cryogenic API synthesis from early-stage to commercial scale.

Services: 9. Modalities: 1. Indications: 0. Locations: 7. Certifications: 1. The strongest documented coverage currently appears in services (9).

### Services

- API Synthesis & Manufacturing
- HPAPI Manufacturing (High-Potency)
- Flow Chemistry & Continuous Manufacturing
- Solid-State Chemistry & Polymorph Screening
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development
- Formulation development
- Solid-state characterization

### Manufacturing capabilities

- Drug Substance (DS)
- HPAPI
- Flow Chemistry
- Cryogenic (−80 °C)